AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...
New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...
In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a ...
Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...
The FDA has told the makers of six flu vaccines that they need to add a notification to the label of their shots, warning of ...
The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback